|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-10-23
|
|
pubmed:abstractText |
The attack rate of cytomegalovirus (CMV) is over 50% in solid organ transplant recipients at risk for primary CMV infection and in those receiving antilymphocyte antibody therapy. Various CMV prophylaxis regimens over the last few years have reduced the attack rate to around 20% overall.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
931-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9326425-Acyclovir,
pubmed-meshheading:9326425-Administration, Oral,
pubmed-meshheading:9326425-Adolescent,
pubmed-meshheading:9326425-Adult,
pubmed-meshheading:9326425-Aged,
pubmed-meshheading:9326425-Antilymphocyte Serum,
pubmed-meshheading:9326425-Antiviral Agents,
pubmed-meshheading:9326425-Creatinine,
pubmed-meshheading:9326425-Cytomegalovirus Infections,
pubmed-meshheading:9326425-Drug Therapy, Combination,
pubmed-meshheading:9326425-Ganciclovir,
pubmed-meshheading:9326425-Humans,
pubmed-meshheading:9326425-Immunosuppressive Agents,
pubmed-meshheading:9326425-Injections, Intravenous,
pubmed-meshheading:9326425-Kidney Transplantation,
pubmed-meshheading:9326425-Middle Aged,
pubmed-meshheading:9326425-Pancreas Transplantation,
pubmed-meshheading:9326425-Postoperative Complications,
pubmed-meshheading:9326425-Recurrence,
pubmed-meshheading:9326425-Retrospective Studies,
pubmed-meshheading:9326425-Risk Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation.
|
|
pubmed:affiliation |
Multi-Organ Transplant Center, Stanford University Medical Center, California 94305, USA.
|
|
pubmed:publicationType |
Journal Article
|
